To secure a rapid and sufficient supply of vaccines and medicines, the global south has asked for a waiver of intellectual property rights. But despite the gravity of the situation, that is rejected outright by the EU. That should not come as a surprise. A briefing from CEO outlines the EU's traditional role as a staunch defender of big pharma monopolies, and how the push for provisions on 'data exclusivity' in trade agreements with third countries have seeked to undermine even existing flexibility under international rules.

Chemical giant's lobbyists woo MEPs via online wine tasting, just as the battle over pesticides reduction proposed by the European Green Deal heats up. But does this event comply with existing rules on lobbying gifts and events targeting MEPs?

A detailed summary of the findings and conclusions of two extensive reports on research public-private partnerships in the EU: the Innovative Medicines Initiative (IMI) and the Bio-Based Industries (BBI) Joint Undertakings.

Despite strong calls from MEPs and the public, ExxonMobil and its lobby groups mobilise enough behind-the-scenes pressure to stop the European Parliament taking away its lobby badges

In this new episode of EU Watchdog Radio, we take a closer look at the European Green Deal (EGD) and in particular how it is being financed. Counter Balance released their latest report on October 20, 2021. In “The European Green Deal: Reclaiming Public Investments for a real Socio-ecological Transformation” Counter Balance shows that the financial basis of the EGD is undersized and wobbly at best.

The EU Green Deal includes bold promises to vastly reduce the use of toxic pesticides. But big pesticide corporations like Bayer, BASF, Syngenta and Corteva are lobbying hard to counter these initiatives. They also want to continue producing and exporting pesticides that are banned in Europe to other countries. This video tells the story of toxic pesticides, international trade and these EU Green Deal promises.

A new report by Corporate Europe Observatory and Observatoire des multinationales, released today, pulls the curtain on the preparation of France's Presidency of the EU, which will start in January 2022. It finds worrying evidence that the Presidency of the Council risks being instrumentalised in favour of a corporate agenda shared by the French government and big business.

In January France will take over the Presidency of the EU Council for six months. But the early signs are worrying that this will be a pro-corporate presidency which prioritises a handful of corporate ‘champions’, and an ever greater role for big business in policy-making.

Tomorrow EU and US counterparts will sit down together for the first meeting of the EU-US Trade and Technology Council (TTC). This is a new transatlantic 'regulatory cooperation' effort with a special focus on the tech sector. Much is at stake in these discussions: from regulating tech giants to standards for artificial intelligence. Corporate lobbyists are keen to get a new industry-driven tool.

The Member of the European Parliament leading the influential energy committee’s work on the future of EU support for major energy projects is pushing the European Parliament to back renewed support for fossil gas - in line with demands of the gas industry – whilst refusing to reveal his meetings with gas lobbyists